A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Access Catheters

Trial Profile

A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Access Catheters

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Jan 2016

At a glance

  • Drugs Tenecteplase (Primary)
  • Indications Catheter thrombosis
  • Focus Therapeutic Use
  • Acronyms TROPICS-2
  • Sponsors Genentech
  • Most Recent Events

    • 25 Jan 2016 Last checked against ClinicalTrials.gov
    • 29 Mar 2011 Primary endpoint identified as treatment success as reported by ClinicalTrials.gov.
    • 24 Dec 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top